Rituximab as a rescue treatment added on mycophenolate mofetil background therapy in progressive systemic sclerosis associated interstitial lung disease unresponsive to conventional immunosuppression
Javier Narváez, Judit Lluch, María Molina‐Molina, Vanesa Vicens‐Zygmunt, Patricio Luburich, Marcos Anibal Yañez, Joan M. Nolla
Topics & Concepts
MedicineRituximabInterstitial lung diseaseInternal medicinePrednisoneGastroenterologyCyclophosphamideImmunosuppressionAdverse effectMycophenolic acidRetrospective cohort studyPulmonary function testingSurgeryLungTransplantationChemotherapyLymphomaSystemic Sclerosis and Related DiseasesInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisTransplantation: Methods and Outcomes